Association between Sleep Disruption and Levels of Lipids in Caucasians with Type 2 Diabetes
Table 3
Standard and hierarchical multiple regression analyses predicting the natural log glucose and log HbA1c (Table 3(a)), SBP and DBP (Table 3(b)), total cholesterol and LDL (Table 3(c)), and Log TG and HDL (Table 3(d)), from sleep duration and sleep quality.
(a)
Outcome: Log glucose
Outcome: Log HbA1c
Model 1 (unadjusted)
Model 2 (adjusted)*
Model 1 (unadjusted)
Model 2 (adjusted)*
Sleep duration (h)
Sleep duration (h)
0.184
0.21
0.038
−0.024
Part correlation
0.11
0.13
Part correlation
0.022
−0.014
0.25
0.19
0.813
0.886
Sleep quality (PSQI score)
Sleep quality (PSQI score)
0.187
0.24
0.107
0.038
Part correlation
0.11
0.14
Part correlation
0.064
0.021
0.24
0.16
0.499
0.826
(b)
Outcome: SBP
Outcome: DBP
Model 1 (unadjusted)
Model 2 (adjusted)*
Model 1 (unadjusted)
Model 2 (adjusted)*
Sleep duration (h)
Sleep duration (h)
0.167
0.076
0.084
0.051
Part correlation
0.1
0.043
Part correlation
0.05
0.029
0.284
0.64
0.593
0.759
Sleep quality (PSQI score)
Sleep quality (PSQI score)
0.32
0.194
0.187
0.126
Part correlation
0.92
0.107
Part correlation
0.112
0.07
0.041
0.249
0.237
0.465
(c)
Outcome: total cholesterol
Outcome: LDL
Model 1 (unadjusted)
Model 2 (adjusted)*
Model 1 (unadjusted)
Model 2 (adjusted)*
Sleep duration (h)
Sleep duration (h)
0.506
0.561
0.294
0.393
Part correlation
0.302
0.322
Part correlation
0.176
0.226
0.001
0.001
0.065
0.016
Sleep quality (PSQI score)
Sleep quality (PSQI score)
0.617
0.675
0.334
0.438
Part correlation
0.369
0.372
Part correlation
0.2
0.242
0.001
0.002
0.036
0.01
(d)
Outcome: HDL
Outcome: Log TG
Model 1 (unadjusted)
Model 2 (adjusted)*
Model 1 (unadjusted)
Model 2 (adjusted)*
Sleep duration (h)
Sleep duration (h)
0.34
0.304
0.142
0.122
Part correlation
0.203
0.174
Part correlation
0.085
0.07
0.032
0.06
0.364
0.453
Sleep quality (PSQI score)
Sleep quality (PSQI score)
0.285
0.214
0.285
0.279
Part correlation
0.17
0.118
Part correlation
0.17
0.154
0.072
0.201
0.07
0.101
Bold face type indicates statistically significant results. *Model 2 is adjusted for age, sex, BMI, and treatment with lipid-lowering agent.